

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 6.29739139 |
| 2 | central nervous system myelination (GO:0022010) | 6.29739139 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.17823541 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.17823541 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.67828837 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.67828837 |
| 7 | presynaptic membrane organization (GO:0097090) | 4.45062855 |
| 8 | blood coagulation, intrinsic pathway (GO:0007597) | 4.41995874 |
| 9 | presynaptic membrane assembly (GO:0097105) | 4.19895304 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 4.06205257 |
| 11 | epoxygenase P450 pathway (GO:0019373) | 4.00022385 |
| 12 | cellular ketone body metabolic process (GO:0046950) | 3.95571887 |
| 13 | glyoxylate metabolic process (GO:0046487) | 3.94501598 |
| 14 | protein carboxylation (GO:0018214) | 3.93250083 |
| 15 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.93250083 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.92239222 |
| 17 | exogenous drug catabolic process (GO:0042738) | 3.90761441 |
| 18 | drug catabolic process (GO:0042737) | 3.82823117 |
| 19 | protein neddylation (GO:0045116) | 3.82273308 |
| 20 | fatty acid elongation (GO:0030497) | 3.80926230 |
| 21 | regulation of fibrinolysis (GO:0051917) | 3.71013428 |
| 22 | neuron cell-cell adhesion (GO:0007158) | 3.69574659 |
| 23 | photoreceptor cell differentiation (GO:0046530) | 3.60733470 |
| 24 | eye photoreceptor cell differentiation (GO:0001754) | 3.60733470 |
| 25 | regulation of protein activation cascade (GO:2000257) | 3.58220485 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 3.56465873 |
| 27 | axoneme assembly (GO:0035082) | 3.53989465 |
| 28 | reverse cholesterol transport (GO:0043691) | 3.51356681 |
| 29 | ketone body metabolic process (GO:1902224) | 3.45327072 |
| 30 | acylglycerol homeostasis (GO:0055090) | 3.45179752 |
| 31 | triglyceride homeostasis (GO:0070328) | 3.45179752 |
| 32 | regulation of complement activation (GO:0030449) | 3.42417453 |
| 33 | xenobiotic catabolic process (GO:0042178) | 3.41545243 |
| 34 | phenylpropanoid metabolic process (GO:0009698) | 3.35182408 |
| 35 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.33476793 |
| 36 | S-adenosylmethionine metabolic process (GO:0046500) | 3.27418108 |
| 37 | aldehyde catabolic process (GO:0046185) | 3.27361136 |
| 38 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.26774385 |
| 39 | fibrinolysis (GO:0042730) | 3.24968033 |
| 40 | regulation of lipoprotein metabolic process (GO:0050746) | 3.23842965 |
| 41 | neurotransmitter uptake (GO:0001504) | 3.22121807 |
| 42 | tyrosine metabolic process (GO:0006570) | 3.21280687 |
| 43 | bile acid biosynthetic process (GO:0006699) | 3.19368495 |
| 44 | dopamine transport (GO:0015872) | 3.17254061 |
| 45 | negative regulation of neurotransmitter transport (GO:0051589) | 3.16696476 |
| 46 | omega-hydroxylase P450 pathway (GO:0097267) | 3.16084041 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 3.15843735 |
| 48 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.15598265 |
| 49 | ethanol oxidation (GO:0006069) | 3.14436439 |
| 50 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.12071140 |
| 51 | bile acid metabolic process (GO:0008206) | 3.08148157 |
| 52 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.07420184 |
| 53 | cilium movement (GO:0003341) | 3.07395478 |
| 54 | myelination (GO:0042552) | 3.06830689 |
| 55 | serine family amino acid catabolic process (GO:0009071) | 3.06285729 |
| 56 | neuronal action potential propagation (GO:0019227) | 3.05149618 |
| 57 | drug metabolic process (GO:0017144) | 3.04535622 |
| 58 | oxidative demethylation (GO:0070989) | 3.00382750 |
| 59 | response to redox state (GO:0051775) | 2.99658542 |
| 60 | axon ensheathment (GO:0008366) | 2.98503198 |
| 61 | ensheathment of neurons (GO:0007272) | 2.98503198 |
| 62 | retinal metabolic process (GO:0042574) | 2.97522717 |
| 63 | neuron remodeling (GO:0016322) | 2.97202822 |
| 64 | cellular glucuronidation (GO:0052695) | 2.96400651 |
| 65 | sensory perception of smell (GO:0007608) | 2.95417013 |
| 66 | protein-lipid complex remodeling (GO:0034368) | 2.94157204 |
| 67 | macromolecular complex remodeling (GO:0034367) | 2.94157204 |
| 68 | plasma lipoprotein particle remodeling (GO:0034369) | 2.94157204 |
| 69 | uronic acid metabolic process (GO:0006063) | 2.93112736 |
| 70 | glucuronate metabolic process (GO:0019585) | 2.93112736 |
| 71 | arginine metabolic process (GO:0006525) | 2.92635137 |
| 72 | negative regulation of fibrinolysis (GO:0051918) | 2.91129197 |
| 73 | magnesium ion transport (GO:0015693) | 2.89296559 |
| 74 | detection of calcium ion (GO:0005513) | 2.89103094 |
| 75 | GPI anchor biosynthetic process (GO:0006506) | 2.88756580 |
| 76 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.87782843 |
| 77 | protein localization to cilium (GO:0061512) | 2.87100851 |
| 78 | oligodendrocyte differentiation (GO:0048709) | 2.85264490 |
| 79 | glycine metabolic process (GO:0006544) | 2.84170728 |
| 80 | branched-chain amino acid catabolic process (GO:0009083) | 2.84084409 |
| 81 | amino-acid betaine metabolic process (GO:0006577) | 2.83727210 |
| 82 | negative regulation of protein activation cascade (GO:2000258) | 2.82338754 |
| 83 | dopamine biosynthetic process (GO:0042416) | 2.81239746 |
| 84 | mannosylation (GO:0097502) | 2.81163465 |
| 85 | cysteine metabolic process (GO:0006534) | 2.78699768 |
| 86 | GPI anchor metabolic process (GO:0006505) | 2.73921137 |
| 87 | alpha-amino acid catabolic process (GO:1901606) | 2.73249579 |
| 88 | ATP synthesis coupled proton transport (GO:0015986) | 2.72551556 |
| 89 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.72551556 |
| 90 | negative regulation of protein localization to cell surface (GO:2000009) | 2.72332244 |
| 91 | negative regulation of cholesterol transport (GO:0032375) | 2.72131317 |
| 92 | negative regulation of sterol transport (GO:0032372) | 2.72131317 |
| 93 | regulation of cholesterol esterification (GO:0010872) | 2.70343941 |
| 94 | postsynaptic membrane organization (GO:0001941) | 2.69933803 |
| 95 | nucleotide transmembrane transport (GO:1901679) | 2.69197032 |
| 96 | glycerophospholipid catabolic process (GO:0046475) | 2.69113921 |
| 97 | aromatic amino acid family metabolic process (GO:0009072) | 2.68309998 |
| 98 | epithelial cilium movement (GO:0003351) | 2.66012342 |
| 99 | serine family amino acid metabolic process (GO:0009069) | 2.65463796 |
| 100 | complement activation, alternative pathway (GO:0006957) | 2.65285020 |
| 101 | tetrahydrofolate metabolic process (GO:0046653) | 2.65080862 |
| 102 | intestinal cholesterol absorption (GO:0030299) | 2.62430710 |
| 103 | regulation of glucokinase activity (GO:0033131) | 2.62375063 |
| 104 | regulation of hexokinase activity (GO:1903299) | 2.62375063 |
| 105 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.61599810 |
| 106 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.61414050 |
| 107 | detection of light stimulus involved in visual perception (GO:0050908) | 2.61414050 |
| 108 | negative regulation of complement activation (GO:0045916) | 2.61044157 |
| 109 | axonemal dynein complex assembly (GO:0070286) | 2.60040932 |
| 110 | artery smooth muscle contraction (GO:0014824) | 2.59994465 |
| 111 | platelet dense granule organization (GO:0060155) | 2.59817586 |
| 112 | phospholipid homeostasis (GO:0055091) | 2.59243368 |
| 113 | primary alcohol metabolic process (GO:0034308) | 2.58625468 |
| 114 | amino acid salvage (GO:0043102) | 2.58330852 |
| 115 | L-methionine salvage (GO:0071267) | 2.58330852 |
| 116 | L-methionine biosynthetic process (GO:0071265) | 2.58330852 |
| 117 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.57353921 |
| 118 | terpenoid biosynthetic process (GO:0016114) | 2.57146835 |
| 119 | low-density lipoprotein particle remodeling (GO:0034374) | 2.56819937 |
| 120 | positive regulation of synapse assembly (GO:0051965) | 2.56506870 |
| 121 | coenzyme catabolic process (GO:0009109) | 2.56139328 |
| 122 | neuron recognition (GO:0008038) | 2.55683942 |
| 123 | branched-chain amino acid metabolic process (GO:0009081) | 2.55325329 |
| 124 | transmission of nerve impulse (GO:0019226) | 2.54775676 |
| 125 | heme transport (GO:0015886) | 2.54755195 |
| 126 | cellular amino acid catabolic process (GO:0009063) | 2.54260128 |
| 127 | protein palmitoylation (GO:0018345) | 2.54153303 |
| 128 | negative regulation of blood coagulation (GO:0030195) | 2.53878499 |
| 129 | negative regulation of hemostasis (GO:1900047) | 2.53878499 |
| 130 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.53649345 |
| 131 | tonic smooth muscle contraction (GO:0014820) | 2.53055719 |
| 132 | startle response (GO:0001964) | 2.52977083 |
| 133 | NADH dehydrogenase complex assembly (GO:0010257) | 2.52640212 |
| 134 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.52640212 |
| 135 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.52640212 |
| 136 | regulation of collateral sprouting (GO:0048670) | 2.50543887 |
| 137 | retinol metabolic process (GO:0042572) | 2.50460332 |
| 138 | bile acid and bile salt transport (GO:0015721) | 2.50332384 |
| 139 | L-ascorbic acid metabolic process (GO:0019852) | 2.50204825 |
| 140 | glutamate receptor signaling pathway (GO:0007215) | 2.50094531 |
| 141 | glutathione derivative biosynthetic process (GO:1901687) | 2.49383478 |
| 142 | glutathione derivative metabolic process (GO:1901685) | 2.49383478 |
| 143 | nonmotile primary cilium assembly (GO:0035058) | 2.47668779 |
| 144 | adult walking behavior (GO:0007628) | 2.47327693 |
| 145 | synaptic vesicle exocytosis (GO:0016079) | 2.46330223 |
| 146 | respiratory chain complex IV assembly (GO:0008535) | 2.45387455 |
| 147 | regulation of catecholamine metabolic process (GO:0042069) | 2.45088534 |
| 148 | regulation of dopamine metabolic process (GO:0042053) | 2.45088534 |
| 149 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.44567340 |
| 150 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.44463128 |
| 151 | glutamate secretion (GO:0014047) | 2.42717909 |
| 152 | signal peptide processing (GO:0006465) | 2.42520255 |
| 153 | GTP biosynthetic process (GO:0006183) | 2.42248533 |
| 154 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.40721029 |
| 155 | regulation of vesicle fusion (GO:0031338) | 2.40667412 |
| 156 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.40322914 |
| 157 | regulation of neuron projection regeneration (GO:0070570) | 2.39616035 |
| 158 | regulation of axon regeneration (GO:0048679) | 2.39616035 |
| 159 | synaptic transmission, glutamatergic (GO:0035249) | 2.39455227 |
| 160 | apical protein localization (GO:0045176) | 2.38417020 |
| 161 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.37409781 |
| 162 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.37051110 |
| 163 | photoreceptor cell maintenance (GO:0045494) | 2.36270623 |
| 164 | nucleoside diphosphate catabolic process (GO:0009134) | 2.35979874 |
| 165 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.34164842 |
| 166 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.34045199 |
| 167 | intraciliary transport (GO:0042073) | 2.31375530 |
| 168 | righting reflex (GO:0060013) | 2.30741885 |
| 169 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.30738167 |
| 170 | neuron-neuron synaptic transmission (GO:0007270) | 2.30201262 |
| 171 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.28375722 |
| 172 | limb bud formation (GO:0060174) | 2.28160759 |
| 173 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.27919872 |
| 174 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.27588564 |
| 175 | vocalization behavior (GO:0071625) | 2.26989810 |
| 176 | protein complex biogenesis (GO:0070271) | 2.26846878 |
| 177 | response to epinephrine (GO:0071871) | 2.26572079 |
| 178 | isoprenoid biosynthetic process (GO:0008299) | 2.26400506 |
| 179 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.26246889 |
| 180 | glycolipid biosynthetic process (GO:0009247) | 2.23311282 |
| 181 | positive regulation of action potential (GO:0045760) | 2.22461283 |
| 182 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.22287863 |
| 183 | regulation of synaptic vesicle transport (GO:1902803) | 2.22232980 |
| 184 | cilium morphogenesis (GO:0060271) | 2.22000681 |
| 185 | long-term synaptic potentiation (GO:0060291) | 2.21447324 |
| 186 | adult locomotory behavior (GO:0008344) | 2.21185566 |
| 187 | protein localization to synapse (GO:0035418) | 2.20474820 |
| 188 | substantia nigra development (GO:0021762) | 2.19486534 |
| 189 | respiratory electron transport chain (GO:0022904) | 2.19327135 |
| 190 | cellular potassium ion homeostasis (GO:0030007) | 2.19312219 |
| 191 | L-amino acid import (GO:0043092) | 2.17103136 |
| 192 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.16583930 |
| 193 | electron transport chain (GO:0022900) | 2.16448952 |
| 194 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.16247755 |
| 195 | neuronal action potential (GO:0019228) | 2.15525886 |
| 196 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.15369598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.92882969 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.73436905 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.62975836 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.58569834 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.15993272 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.09640970 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.59507104 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.49272010 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.47582201 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.47273903 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.37990408 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.29182199 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.27066125 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.25639698 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.21147222 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21144483 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.20165226 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.19275248 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.15724156 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.15447188 |
| 21 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.08398059 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.07660864 |
| 23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.07660864 |
| 24 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.07055528 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.06381541 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.05341391 |
| 27 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.03203826 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95725034 |
| 29 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.95268964 |
| 30 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.91323220 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.88821235 |
| 32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.87264462 |
| 33 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.83520296 |
| 34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.79230017 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79064424 |
| 36 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.78518539 |
| 37 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.77435993 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.77204211 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76110754 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.74699896 |
| 41 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.74503185 |
| 42 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.74472190 |
| 43 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.72450301 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.72086201 |
| 45 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.68379291 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.66283680 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.63791050 |
| 48 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.63736464 |
| 49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.63130410 |
| 50 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.61325913 |
| 51 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.59983447 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59528647 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.57824012 |
| 54 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.56615173 |
| 55 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.55121501 |
| 56 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.51551130 |
| 57 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.50844061 |
| 58 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.49838413 |
| 59 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.49296366 |
| 60 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.45037029 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42635555 |
| 62 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.39932620 |
| 63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39666285 |
| 64 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.39289424 |
| 65 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.38865367 |
| 66 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38509349 |
| 67 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.37564770 |
| 68 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.36110085 |
| 69 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.35547013 |
| 70 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.35155392 |
| 71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.34824729 |
| 72 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.30083997 |
| 73 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.28653280 |
| 74 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28616353 |
| 75 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.28364489 |
| 76 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.26051283 |
| 77 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24854788 |
| 78 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.24833028 |
| 79 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.24544646 |
| 80 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23307789 |
| 81 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.23281893 |
| 82 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23185485 |
| 83 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23185485 |
| 84 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.22503713 |
| 85 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.21763241 |
| 86 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21261247 |
| 87 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.20246149 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20209505 |
| 89 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.17461635 |
| 90 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.16257899 |
| 91 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.15649288 |
| 92 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15556132 |
| 93 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.15027853 |
| 94 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.13815858 |
| 95 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.12589388 |
| 96 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.11798002 |
| 97 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.11751515 |
| 98 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.11751515 |
| 99 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.11662650 |
| 100 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11216667 |
| 101 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.11005697 |
| 102 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10782432 |
| 103 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.10334696 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10282934 |
| 105 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09948959 |
| 106 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09758447 |
| 107 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09680779 |
| 108 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.09375361 |
| 109 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08408350 |
| 110 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.08070362 |
| 111 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.07454397 |
| 112 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06704503 |
| 113 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06412855 |
| 114 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05899961 |
| 115 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.05536835 |
| 116 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05483516 |
| 117 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.04759702 |
| 118 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.04753450 |
| 119 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04002336 |
| 120 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.03984604 |
| 121 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03781339 |
| 122 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.03107156 |
| 123 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.02832733 |
| 124 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.02456988 |
| 125 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.02413395 |
| 126 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.01850097 |
| 127 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01276725 |
| 128 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01202654 |
| 129 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01202654 |
| 130 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.01106113 |
| 131 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.00878673 |
| 132 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.00285450 |
| 133 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00252892 |
| 134 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99553761 |
| 135 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99553761 |
| 136 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.99161217 |
| 137 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.99091249 |
| 138 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98906464 |
| 139 | JUN_21703547_ChIP-Seq_K562_Human | 0.98848179 |
| 140 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98227613 |
| 141 | NFYA_21822215_ChIP-Seq_K562_Human | 0.97757249 |
| 142 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.97141968 |
| 143 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96420675 |
| 144 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96361637 |
| 145 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95675281 |
| 146 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.95566889 |
| 147 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.95195697 |
| 148 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.95079058 |
| 149 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94978935 |
| 150 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94881475 |
| 151 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94444514 |
| 152 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93952181 |
| 153 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93894434 |
| 154 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92867807 |
| 155 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.92729525 |
| 156 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91558699 |
| 157 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91558699 |
| 158 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91030245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.32821000 |
| 2 | MP0003880_abnormal_central_pattern | 4.11640134 |
| 3 | MP0005365_abnormal_bile_salt | 3.53400827 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.35893017 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.11852466 |
| 6 | MP0005360_urolithiasis | 3.02385579 |
| 7 | MP0010329_abnormal_lipoprotein_level | 2.81187377 |
| 8 | MP0004270_analgesia | 2.65489982 |
| 9 | MP0001984_abnormal_olfaction | 2.56620482 |
| 10 | MP0005332_abnormal_amino_acid | 2.49210447 |
| 11 | MP0002272_abnormal_nervous_system | 2.48542074 |
| 12 | MP0009697_abnormal_copulation | 2.38440837 |
| 13 | MP0003122_maternal_imprinting | 2.34469409 |
| 14 | MP0003635_abnormal_synaptic_transmissio | 2.34069085 |
| 15 | MP0003136_yellow_coat_color | 2.32615229 |
| 16 | MP0005171_absent_coat_pigmentation | 2.30662088 |
| 17 | MP0001486_abnormal_startle_reflex | 2.28345702 |
| 18 | MP0000920_abnormal_myelination | 2.24918905 |
| 19 | MP0001188_hyperpigmentation | 2.22080331 |
| 20 | MP0009745_abnormal_behavioral_response | 2.20313833 |
| 21 | MP0005423_abnormal_somatic_nervous | 2.18332944 |
| 22 | MP0004859_abnormal_synaptic_plasticity | 2.17295482 |
| 23 | MP0002064_seizures | 2.17021231 |
| 24 | MP0001529_abnormal_vocalization | 2.16864511 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 2.14822390 |
| 26 | MP0005646_abnormal_pituitary_gland | 2.08737394 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 2.08604317 |
| 28 | MP0001968_abnormal_touch/_nociception | 2.07457282 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 2.01321001 |
| 30 | MP0002736_abnormal_nociception_after | 2.00283382 |
| 31 | MP0003186_abnormal_redox_activity | 1.99020538 |
| 32 | MP0004142_abnormal_muscle_tone | 1.98021665 |
| 33 | MP0001905_abnormal_dopamine_level | 1.95500143 |
| 34 | MP0001666_abnormal_nutrient_absorption | 1.94875552 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.94073893 |
| 36 | MP0003011_delayed_dark_adaptation | 1.93275112 |
| 37 | MP0005551_abnormal_eye_electrophysiolog | 1.92747533 |
| 38 | MP0009046_muscle_twitch | 1.92531368 |
| 39 | MP0004742_abnormal_vestibular_system | 1.92015483 |
| 40 | MP0003252_abnormal_bile_duct | 1.91406022 |
| 41 | MP0001986_abnormal_taste_sensitivity | 1.86352869 |
| 42 | MP0002063_abnormal_learning/memory/cond | 1.81905763 |
| 43 | MP0002735_abnormal_chemical_nociception | 1.80955653 |
| 44 | MP0003868_abnormal_feces_composition | 1.80531139 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.77612369 |
| 46 | MP0004043_abnormal_pH_regulation | 1.77533800 |
| 47 | MP0001501_abnormal_sleep_pattern | 1.76538887 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.73437870 |
| 49 | MP0002733_abnormal_thermal_nociception | 1.72086746 |
| 50 | MP0001970_abnormal_pain_threshold | 1.72074390 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.71560513 |
| 52 | MP0010386_abnormal_urinary_bladder | 1.67892487 |
| 53 | MP0002067_abnormal_sensory_capabilities | 1.67781968 |
| 54 | MP0002638_abnormal_pupillary_reflex | 1.66531218 |
| 55 | MP0001440_abnormal_grooming_behavior | 1.59259655 |
| 56 | MP0005464_abnormal_platelet_physiology | 1.58367317 |
| 57 | MP0002118_abnormal_lipid_homeostasis | 1.55973714 |
| 58 | MP0003123_paternal_imprinting | 1.55321549 |
| 59 | MP0005636_abnormal_mineral_homeostasis | 1.54580830 |
| 60 | MP0000778_abnormal_nervous_system | 1.51897579 |
| 61 | MP0001764_abnormal_homeostasis | 1.49273380 |
| 62 | MP0005379_endocrine/exocrine_gland_phen | 1.48108299 |
| 63 | MP0002184_abnormal_innervation | 1.46838349 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.45292757 |
| 65 | MP0004381_abnormal_hair_follicle | 1.45019962 |
| 66 | MP0003329_amyloid_beta_deposits | 1.42425463 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 1.40511342 |
| 68 | MP0001661_extended_life_span | 1.39502213 |
| 69 | MP0003718_maternal_effect | 1.37000248 |
| 70 | MP0002229_neurodegeneration | 1.32312028 |
| 71 | MP0004924_abnormal_behavior | 1.31786111 |
| 72 | MP0005386_behavior/neurological_phenoty | 1.31786111 |
| 73 | MP0001485_abnormal_pinna_reflex | 1.31734189 |
| 74 | MP0005409_darkened_coat_color | 1.31054582 |
| 75 | MP0008569_lethality_at_weaning | 1.29347495 |
| 76 | MP0006072_abnormal_retinal_apoptosis | 1.28203048 |
| 77 | MP0008872_abnormal_physiological_respon | 1.28140818 |
| 78 | MP0003634_abnormal_glial_cell | 1.27067513 |
| 79 | MP0003690_abnormal_glial_cell | 1.24038256 |
| 80 | MP0002882_abnormal_neuron_morphology | 1.23855191 |
| 81 | MP0005408_hypopigmentation | 1.22260900 |
| 82 | MP0003195_calcinosis | 1.20731983 |
| 83 | MP0000462_abnormal_digestive_system | 1.17909071 |
| 84 | MP0008775_abnormal_heart_ventricle | 1.16751494 |
| 85 | MP0002752_abnormal_somatic_nervous | 1.15679513 |
| 86 | MP0001756_abnormal_urination | 1.15449747 |
| 87 | MP0003950_abnormal_plasma_membrane | 1.14836983 |
| 88 | MP0001963_abnormal_hearing_physiology | 1.14703273 |
| 89 | MP0008877_abnormal_DNA_methylation | 1.14490568 |
| 90 | MP0000955_abnormal_spinal_cord | 1.13580484 |
| 91 | MP0006035_abnormal_mitochondrial_morpho | 1.13388351 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 1.13281142 |
| 93 | MP0003283_abnormal_digestive_organ | 1.12725745 |
| 94 | MP0001944_abnormal_pancreas_morphology | 1.11428786 |
| 95 | MP0001664_abnormal_digestion | 1.10821149 |
| 96 | MP0004145_abnormal_muscle_electrophysio | 1.09678399 |
| 97 | MP0000631_abnormal_neuroendocrine_gland | 1.08095043 |
| 98 | MP0009379_abnormal_foot_pigmentation | 1.07533058 |
| 99 | MP0000566_synostosis | 1.06264798 |
| 100 | MP0004215_abnormal_myocardial_fiber | 1.06083406 |
| 101 | MP0004885_abnormal_endolymph | 1.04816114 |
| 102 | MP0002066_abnormal_motor_capabilities/c | 1.04010620 |
| 103 | MP0000372_irregular_coat_pigmentation | 1.03706489 |
| 104 | MP0006292_abnormal_olfactory_placode | 1.01522075 |
| 105 | MP0004134_abnormal_chest_morphology | 1.01339615 |
| 106 | MP0003633_abnormal_nervous_system | 1.01200841 |
| 107 | MP0005253_abnormal_eye_physiology | 0.99702963 |
| 108 | MP0003121_genomic_imprinting | 0.98393167 |
| 109 | MP0000026_abnormal_inner_ear | 0.97680262 |
| 110 | MP0002132_abnormal_respiratory_system | 0.97442924 |
| 111 | MP0003953_abnormal_hormone_level | 0.97094998 |
| 112 | MP0002234_abnormal_pharynx_morphology | 0.96790483 |
| 113 | MP0004147_increased_porphyrin_level | 0.96725831 |
| 114 | MP0005187_abnormal_penis_morphology | 0.96653113 |
| 115 | MP0005670_abnormal_white_adipose | 0.95666891 |
| 116 | MP0009780_abnormal_chondrocyte_physiolo | 0.95551873 |
| 117 | MP0005448_abnormal_energy_balance | 0.93668409 |
| 118 | MP0002090_abnormal_vision | 0.93164385 |
| 119 | MP0008004_abnormal_stomach_pH | 0.93140160 |
| 120 | MP0009643_abnormal_urine_homeostasis | 0.93108505 |
| 121 | MP0005083_abnormal_biliary_tract | 0.92456753 |
| 122 | MP0002138_abnormal_hepatobiliary_system | 0.91114024 |
| 123 | MP0003656_abnormal_erythrocyte_physiolo | 0.90136422 |
| 124 | MP0000609_abnormal_liver_physiology | 0.89280041 |
| 125 | MP0002876_abnormal_thyroid_physiology | 0.88045365 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.87087349 |
| 127 | MP0003631_nervous_system_phenotype | 0.86379710 |
| 128 | MP0002822_catalepsy | 0.86214393 |
| 129 | MP0009840_abnormal_foam_cell | 0.86005718 |
| 130 | MP0005195_abnormal_posterior_eye | 0.84757084 |
| 131 | MP0002163_abnormal_gland_morphology | 0.81634899 |
| 132 | MP0009642_abnormal_blood_homeostasis | 0.80783166 |
| 133 | MP0002938_white_spotting | 0.75783848 |
| 134 | MP0003632_abnormal_nervous_system | 0.75281867 |
| 135 | MP0001765_abnormal_ion_homeostasis | 0.74339111 |
| 136 | MP0000013_abnormal_adipose_tissue | 0.74296563 |
| 137 | MP0002295_abnormal_pulmonary_circulatio | 0.73628774 |
| 138 | MP0002971_abnormal_brown_adipose | 0.73572041 |
| 139 | MP0002693_abnormal_pancreas_physiology | 0.73294303 |
| 140 | MP0004085_abnormal_heartbeat | 0.72027247 |
| 141 | MP0008995_early_reproductive_senescence | 0.71924950 |
| 142 | MP0002102_abnormal_ear_morphology | 0.71582142 |
| 143 | MP0003879_abnormal_hair_cell | 0.71511085 |
| 144 | MP0001346_abnormal_lacrimal_gland | 0.71427470 |
| 145 | MP0000639_abnormal_adrenal_gland | 0.70540144 |
| 146 | MP0003137_abnormal_impulse_conducting | 0.70302848 |
| 147 | MP0005084_abnormal_gallbladder_morpholo | 0.68894573 |
| 148 | MP0000230_abnormal_systemic_arterial | 0.68892310 |
| 149 | MP0005410_abnormal_fertilization | 0.68869725 |
| 150 | MP0002909_abnormal_adrenal_gland | 0.68697509 |
| 151 | MP0005595_abnormal_vascular_smooth | 0.68204139 |
| 152 | MP0002837_dystrophic_cardiac_calcinosis | 0.67009701 |
| 153 | MP0003183_abnormal_peptide_metabolism | 0.66757540 |
| 154 | MP0000647_abnormal_sebaceous_gland | 0.66378781 |
| 155 | MP0001851_eye_inflammation | 0.64224795 |
| 156 | MP0005535_abnormal_body_temperature | 0.63482112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.96761465 |
| 2 | Abnormal ciliary motility (HP:0012262) | 4.61597947 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 4.49462433 |
| 4 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.15738524 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 3.87314871 |
| 6 | Retinal dysplasia (HP:0007973) | 3.86949465 |
| 7 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.86499986 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 3.80391345 |
| 9 | Hypothermia (HP:0002045) | 3.70575748 |
| 10 | Neurofibrillary tangles (HP:0002185) | 3.65806108 |
| 11 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.45481164 |
| 12 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.45481164 |
| 13 | Focal motor seizures (HP:0011153) | 3.44761321 |
| 14 | Xanthomatosis (HP:0000991) | 3.39147923 |
| 15 | Hypoglycemic coma (HP:0001325) | 3.32781901 |
| 16 | Limb dystonia (HP:0002451) | 3.19525048 |
| 17 | Menorrhagia (HP:0000132) | 3.16115655 |
| 18 | Rhinitis (HP:0012384) | 3.12752686 |
| 19 | Deep venous thrombosis (HP:0002625) | 3.11626057 |
| 20 | Gait imbalance (HP:0002141) | 3.07394211 |
| 21 | Cholecystitis (HP:0001082) | 2.97614290 |
| 22 | Abnormal gallbladder physiology (HP:0012438) | 2.97614290 |
| 23 | Medial flaring of the eyebrow (HP:0010747) | 2.96711289 |
| 24 | Joint hemorrhage (HP:0005261) | 2.96422875 |
| 25 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.96037547 |
| 26 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.96037547 |
| 27 | Hepatic necrosis (HP:0002605) | 2.94832657 |
| 28 | Hyperglycinemia (HP:0002154) | 2.88989723 |
| 29 | Congenital primary aphakia (HP:0007707) | 2.86053415 |
| 30 | Absent/shortened dynein arms (HP:0200106) | 2.85827443 |
| 31 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.85827443 |
| 32 | Nephrogenic diabetes insipidus (HP:0009806) | 2.85415029 |
| 33 | Cerebral edema (HP:0002181) | 2.85015057 |
| 34 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.83155171 |
| 35 | Acute necrotizing encephalopathy (HP:0006965) | 2.80308782 |
| 36 | Glycosuria (HP:0003076) | 2.79187979 |
| 37 | Abnormality of urine glucose concentration (HP:0011016) | 2.79187979 |
| 38 | Ketoacidosis (HP:0001993) | 2.77884001 |
| 39 | Abnormality of methionine metabolism (HP:0010901) | 2.76847302 |
| 40 | Genital tract atresia (HP:0001827) | 2.69916719 |
| 41 | Complement deficiency (HP:0004431) | 2.69835873 |
| 42 | Vaginal atresia (HP:0000148) | 2.69702486 |
| 43 | Myokymia (HP:0002411) | 2.69110475 |
| 44 | Abnormality of the common coagulation pathway (HP:0010990) | 2.67155324 |
| 45 | Generalized aminoaciduria (HP:0002909) | 2.66116974 |
| 46 | Acanthocytosis (HP:0001927) | 2.65583138 |
| 47 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.65540284 |
| 48 | Hypoglycemic seizures (HP:0002173) | 2.64446641 |
| 49 | Hyperthyroidism (HP:0000836) | 2.64275596 |
| 50 | Epileptic encephalopathy (HP:0200134) | 2.64188507 |
| 51 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.56693878 |
| 52 | Abnormality of glycolysis (HP:0004366) | 2.56232576 |
| 53 | Increased serum pyruvate (HP:0003542) | 2.56205274 |
| 54 | Abnormality of macular pigmentation (HP:0008002) | 2.55332192 |
| 55 | Poikilocytosis (HP:0004447) | 2.53917212 |
| 56 | Conjugated hyperbilirubinemia (HP:0002908) | 2.49494963 |
| 57 | Febrile seizures (HP:0002373) | 2.48261118 |
| 58 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.45879230 |
| 59 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.45639742 |
| 60 | Mitochondrial inheritance (HP:0001427) | 2.44563590 |
| 61 | Lethargy (HP:0001254) | 2.42190634 |
| 62 | Supranuclear gaze palsy (HP:0000605) | 2.41258931 |
| 63 | Atonic seizures (HP:0010819) | 2.41199285 |
| 64 | Abnormality of glycine metabolism (HP:0010895) | 2.39980031 |
| 65 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.39980031 |
| 66 | Intrahepatic cholestasis (HP:0001406) | 2.38561639 |
| 67 | Pheochromocytoma (HP:0002666) | 2.38523842 |
| 68 | Parakeratosis (HP:0001036) | 2.37402702 |
| 69 | Peripheral hypomyelination (HP:0007182) | 2.37358503 |
| 70 | Ketosis (HP:0001946) | 2.36431056 |
| 71 | Congenital sensorineural hearing impairment (HP:0008527) | 2.36294449 |
| 72 | Progressive macrocephaly (HP:0004481) | 2.34997436 |
| 73 | Abnormal pupillary function (HP:0007686) | 2.33353613 |
| 74 | Hyperphosphaturia (HP:0003109) | 2.33274395 |
| 75 | Renal Fanconi syndrome (HP:0001994) | 2.32760366 |
| 76 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.32734702 |
| 77 | Abnormality of serum amino acid levels (HP:0003112) | 2.30931830 |
| 78 | Vascular calcification (HP:0004934) | 2.29778931 |
| 79 | Prolonged bleeding time (HP:0003010) | 2.29564856 |
| 80 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.29106135 |
| 81 | Scanning speech (HP:0002168) | 2.27961175 |
| 82 | Neuroendocrine neoplasm (HP:0100634) | 2.26738980 |
| 83 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.25873811 |
| 84 | Type II lissencephaly (HP:0007260) | 2.25556997 |
| 85 | Hyperglycinuria (HP:0003108) | 2.24913030 |
| 86 | Epidermoid cyst (HP:0200040) | 2.24302704 |
| 87 | Central scotoma (HP:0000603) | 2.23377876 |
| 88 | Cerebral inclusion bodies (HP:0100314) | 2.23362106 |
| 89 | Lipid accumulation in hepatocytes (HP:0006561) | 2.22349541 |
| 90 | Abnormality of vitamin metabolism (HP:0100508) | 2.22332889 |
| 91 | Patchy hypopigmentation of hair (HP:0011365) | 2.22143626 |
| 92 | Congenital stationary night blindness (HP:0007642) | 2.19717923 |
| 93 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.17440223 |
| 94 | Hypolipoproteinemia (HP:0010981) | 2.17035744 |
| 95 | Thickened helices (HP:0000391) | 2.16786838 |
| 96 | Hyperventilation (HP:0002883) | 2.15790658 |
| 97 | Acute encephalopathy (HP:0006846) | 2.15274264 |
| 98 | Ankle clonus (HP:0011448) | 2.15255088 |
| 99 | Increased mean platelet volume (HP:0011877) | 2.13140939 |
| 100 | Spontaneous abortion (HP:0005268) | 2.11908458 |
| 101 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.11212933 |
| 102 | Metabolic alkalosis (HP:0200114) | 2.11036600 |
| 103 | Nonprogressive disorder (HP:0003680) | 2.10893240 |
| 104 | Respiratory failure (HP:0002878) | 2.09469838 |
| 105 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.08892378 |
| 106 | Focal seizures (HP:0007359) | 2.08726371 |
| 107 | Hyperammonemia (HP:0001987) | 2.06837993 |
| 108 | Agitation (HP:0000713) | 2.05617209 |
| 109 | Proximal tubulopathy (HP:0000114) | 2.04895006 |
| 110 | Optic disc pallor (HP:0000543) | 2.03656688 |
| 111 | Alacrima (HP:0000522) | 2.03023668 |
| 112 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.02979976 |
| 113 | Abnormality of alanine metabolism (HP:0010916) | 2.02979976 |
| 114 | Hyperalaninemia (HP:0003348) | 2.02979976 |
| 115 | Purpura (HP:0000979) | 2.01810883 |
| 116 | True hermaphroditism (HP:0010459) | 2.01303267 |
| 117 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.00963269 |
| 118 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.00963269 |
| 119 | Petechiae (HP:0000967) | 2.00886632 |
| 120 | Hypomagnesemia (HP:0002917) | 2.00704875 |
| 121 | Lactic acidosis (HP:0003128) | 2.00614559 |
| 122 | Abnormality of renal resorption (HP:0011038) | 2.00522999 |
| 123 | Abnormality of the corticospinal tract (HP:0002492) | 1.98958961 |
| 124 | Anxiety (HP:0000739) | 1.96840191 |
| 125 | 3-Methylglutaconic aciduria (HP:0003535) | 1.96448127 |
| 126 | Progressive cerebellar ataxia (HP:0002073) | 1.96305464 |
| 127 | Abnormality of the intrinsic pathway (HP:0010989) | 1.95773565 |
| 128 | Metabolic acidosis (HP:0001942) | 1.95645560 |
| 129 | Dysmetria (HP:0001310) | 1.94839979 |
| 130 | Palpitations (HP:0001962) | 1.93747546 |
| 131 | Methylmalonic aciduria (HP:0012120) | 1.93436077 |
| 132 | Broad-based gait (HP:0002136) | 1.93035459 |
| 133 | Decreased circulating renin level (HP:0003351) | 1.92661854 |
| 134 | Hepatocellular necrosis (HP:0001404) | 1.92391103 |
| 135 | Arthropathy (HP:0003040) | 1.92131370 |
| 136 | Hypophosphatemic rickets (HP:0004912) | 1.92003696 |
| 137 | Renal cortical cysts (HP:0000803) | 1.91786274 |
| 138 | Symptomatic seizures (HP:0011145) | 1.90968618 |
| 139 | Blue irides (HP:0000635) | 1.90895574 |
| 140 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.90607310 |
| 141 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.90607310 |
| 142 | Increased circulating renin level (HP:0000848) | 1.89677990 |
| 143 | Hypoplasia of the fovea (HP:0007750) | 1.89374075 |
| 144 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.89374075 |
| 145 | Chronic bronchitis (HP:0004469) | 1.89239983 |
| 146 | Leukodystrophy (HP:0002415) | 1.89145193 |
| 147 | Fat malabsorption (HP:0002630) | 1.89050975 |
| 148 | White forelock (HP:0002211) | 1.88956373 |
| 149 | Cardiovascular calcification (HP:0011915) | 1.88597575 |
| 150 | Clumsiness (HP:0002312) | 1.88304814 |
| 151 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.88082637 |
| 152 | Increased serum lactate (HP:0002151) | 1.87413154 |
| 153 | Abnormality of vitamin B metabolism (HP:0004340) | 1.87085458 |
| 154 | Abnormality of the renal cortex (HP:0011035) | 1.85247011 |
| 155 | Pancreatic fibrosis (HP:0100732) | 1.85108803 |
| 156 | Gingival bleeding (HP:0000225) | 1.84185906 |
| 157 | Abnormality of the fovea (HP:0000493) | 1.83689085 |
| 158 | Increased hepatocellular lipid droplets (HP:0006565) | 1.82816933 |
| 159 | Dialeptic seizures (HP:0011146) | 1.82432070 |
| 160 | Specific learning disability (HP:0001328) | 1.81992778 |
| 161 | Abnormal gallbladder morphology (HP:0012437) | 1.81700012 |
| 162 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.81352311 |
| 163 | Poor coordination (HP:0002370) | 1.81192818 |
| 164 | Abnormality of renin-angiotensin system (HP:0000847) | 1.80882355 |
| 165 | Sensory axonal neuropathy (HP:0003390) | 1.80519927 |
| 166 | Increased CSF lactate (HP:0002490) | 1.79799381 |
| 167 | Abnormality of magnesium homeostasis (HP:0004921) | 1.79496171 |
| 168 | Hyperbilirubinemia (HP:0002904) | 1.78697952 |
| 169 | Abnormality of midbrain morphology (HP:0002418) | 1.77371700 |
| 170 | Molar tooth sign on MRI (HP:0002419) | 1.77371700 |
| 171 | Polyphagia (HP:0002591) | 1.76445768 |
| 172 | Generalized tonic-clonic seizures (HP:0002069) | 1.75962116 |
| 173 | Methylmalonic acidemia (HP:0002912) | 1.74202933 |
| 174 | Absent speech (HP:0001344) | 1.74117717 |
| 175 | Hypokalemic alkalosis (HP:0001949) | 1.73927896 |
| 176 | Onion bulb formation (HP:0003383) | 1.73674403 |
| 177 | Poor speech (HP:0002465) | 1.72447660 |
| 178 | Spastic gait (HP:0002064) | 1.71274870 |
| 179 | Absence seizures (HP:0002121) | 1.71141839 |
| 180 | Atelectasis (HP:0100750) | 1.70863537 |
| 181 | Humeroradial synostosis (HP:0003041) | 1.69413863 |
| 182 | Synostosis involving the elbow (HP:0003938) | 1.69413863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.64415151 |
| 2 | MAPK15 | 3.55222291 |
| 3 | CASK | 3.45138258 |
| 4 | STK39 | 3.09393908 |
| 5 | MAP4K2 | 3.03941551 |
| 6 | EIF2AK1 | 2.83328522 |
| 7 | OXSR1 | 2.64390182 |
| 8 | MAPKAPK5 | 2.51080386 |
| 9 | MUSK | 2.48272777 |
| 10 | TNIK | 2.07678104 |
| 11 | INSRR | 1.89594788 |
| 12 | NTRK3 | 1.89155031 |
| 13 | BMPR1B | 1.88667118 |
| 14 | MAP2K7 | 1.84897933 |
| 15 | NUAK1 | 1.76421377 |
| 16 | BMPR2 | 1.74261893 |
| 17 | PKN1 | 1.69230235 |
| 18 | WNK4 | 1.67785454 |
| 19 | ARAF | 1.67722719 |
| 20 | MARK1 | 1.67421553 |
| 21 | PNCK | 1.64302265 |
| 22 | CDK19 | 1.61563979 |
| 23 | EPHA4 | 1.60142472 |
| 24 | BCR | 1.57706334 |
| 25 | GRK7 | 1.57235506 |
| 26 | MAPK13 | 1.56759705 |
| 27 | CAMK2B | 1.39255827 |
| 28 | MAPKAPK3 | 1.38906826 |
| 29 | PIK3CG | 1.37683120 |
| 30 | TLK1 | 1.37147318 |
| 31 | CAMK2D | 1.34123585 |
| 32 | NEK6 | 1.31404616 |
| 33 | BMX | 1.30966472 |
| 34 | ADRBK2 | 1.30295100 |
| 35 | EPHB1 | 1.28703665 |
| 36 | PHKG2 | 1.27219984 |
| 37 | PHKG1 | 1.27219984 |
| 38 | EIF2AK3 | 1.26207407 |
| 39 | BRSK2 | 1.25498788 |
| 40 | UHMK1 | 1.25379092 |
| 41 | CAMK2A | 1.23943459 |
| 42 | NEK1 | 1.18871123 |
| 43 | ZAK | 1.17987772 |
| 44 | CSNK1G3 | 1.17293287 |
| 45 | NTRK1 | 1.17195083 |
| 46 | STK16 | 1.16492169 |
| 47 | SGK494 | 1.15909227 |
| 48 | SGK223 | 1.15909227 |
| 49 | STK3 | 1.11246037 |
| 50 | BCKDK | 1.11104367 |
| 51 | PLK3 | 1.11018059 |
| 52 | PRKCE | 1.10555010 |
| 53 | CAMKK2 | 1.07347250 |
| 54 | TAOK3 | 1.06639955 |
| 55 | MST4 | 1.04748105 |
| 56 | CAMK2G | 1.01495382 |
| 57 | TRIM28 | 1.01082282 |
| 58 | FES | 1.00600574 |
| 59 | IRAK2 | 1.00097107 |
| 60 | IRAK1 | 0.99984457 |
| 61 | MAP3K12 | 0.99155821 |
| 62 | FER | 0.98293382 |
| 63 | CSNK1G2 | 0.98037669 |
| 64 | FGFR2 | 0.97447262 |
| 65 | GRK1 | 0.96689186 |
| 66 | GRK5 | 0.96101402 |
| 67 | CSNK1A1L | 0.95865753 |
| 68 | PRPF4B | 0.95000444 |
| 69 | NTRK2 | 0.94466106 |
| 70 | CSNK1G1 | 0.93531192 |
| 71 | TIE1 | 0.92629937 |
| 72 | PINK1 | 0.89590157 |
| 73 | HIPK2 | 0.87191452 |
| 74 | CDK5 | 0.86742615 |
| 75 | WNK3 | 0.85151074 |
| 76 | PAK3 | 0.84875144 |
| 77 | NME1 | 0.83866186 |
| 78 | ERBB3 | 0.82720760 |
| 79 | ILK | 0.82143829 |
| 80 | TRPM7 | 0.81923301 |
| 81 | MINK1 | 0.81789710 |
| 82 | MAP3K4 | 0.81729524 |
| 83 | DYRK1A | 0.81056087 |
| 84 | CDK3 | 0.80720747 |
| 85 | PDK2 | 0.80291830 |
| 86 | PLK2 | 0.80023152 |
| 87 | WNK1 | 0.79476484 |
| 88 | ACVR1B | 0.78827050 |
| 89 | AKT3 | 0.78598136 |
| 90 | DYRK2 | 0.77950222 |
| 91 | PAK6 | 0.77529953 |
| 92 | MAP2K6 | 0.77418481 |
| 93 | PTK2B | 0.77137507 |
| 94 | PBK | 0.76030866 |
| 95 | BRAF | 0.74018517 |
| 96 | ROCK2 | 0.72803103 |
| 97 | CCNB1 | 0.72187002 |
| 98 | STK24 | 0.65492084 |
| 99 | RIPK4 | 0.65300912 |
| 100 | PRKG1 | 0.65066818 |
| 101 | CAMK1 | 0.64505902 |
| 102 | MARK2 | 0.64444094 |
| 103 | PRKACG | 0.62091552 |
| 104 | TTK | 0.61828404 |
| 105 | PRKACA | 0.61320948 |
| 106 | PRKCG | 0.60624779 |
| 107 | TNK2 | 0.60224063 |
| 108 | ERBB2 | 0.59427869 |
| 109 | PRKCQ | 0.58803573 |
| 110 | VRK1 | 0.58602164 |
| 111 | DAPK2 | 0.58583249 |
| 112 | PRKAA2 | 0.58433875 |
| 113 | PRKAA1 | 0.58113673 |
| 114 | LIMK1 | 0.58010976 |
| 115 | MAPK12 | 0.56357836 |
| 116 | DMPK | 0.56256934 |
| 117 | CSNK1E | 0.55805783 |
| 118 | STK38L | 0.55610715 |
| 119 | EPHA3 | 0.54404877 |
| 120 | MST1R | 0.52365916 |
| 121 | DAPK3 | 0.51057345 |
| 122 | TEC | 0.48949241 |
| 123 | PRKD2 | 0.48806217 |
| 124 | ADRBK1 | 0.48331023 |
| 125 | FGR | 0.47793868 |
| 126 | STK4 | 0.47319332 |
| 127 | PRKCH | 0.46706366 |
| 128 | CAMK1G | 0.45159765 |
| 129 | CDK8 | 0.44909116 |
| 130 | OBSCN | 0.44838006 |
| 131 | CDC7 | 0.44355281 |
| 132 | MYLK | 0.44242411 |
| 133 | IRAK4 | 0.41723856 |
| 134 | MET | 0.41626426 |
| 135 | MAP3K2 | 0.41406549 |
| 136 | PIK3CA | 0.38309142 |
| 137 | CSNK1A1 | 0.38187091 |
| 138 | MAP3K1 | 0.37713826 |
| 139 | PRKD1 | 0.37505941 |
| 140 | PRKCA | 0.37472590 |
| 141 | CDK14 | 0.37441503 |
| 142 | SIK3 | 0.37165591 |
| 143 | MAP3K9 | 0.36269722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 2.89902393 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.76557321 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.48445779 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.46049148 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.45182008 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.44183332 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.41752647 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.25533403 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.25352683 |
| 10 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.14306777 |
| 11 | Retinol metabolism_Homo sapiens_hsa00830 | 2.11048465 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.10595739 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 2.10264523 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.09709634 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.08088903 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.03086078 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.01446315 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.98074348 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.97628596 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.97517051 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.96159168 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.96076930 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.95866153 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.90971212 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.90768929 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89411679 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88232848 |
| 28 | Morphine addiction_Homo sapiens_hsa05032 | 1.88046873 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87787263 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.87423243 |
| 31 | Olfactory transduction_Homo sapiens_hsa04740 | 1.85504794 |
| 32 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.81111200 |
| 33 | Phototransduction_Homo sapiens_hsa04744 | 1.77931237 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.75614035 |
| 35 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.75488137 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.74923801 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.73337042 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.69584358 |
| 39 | Circadian entrainment_Homo sapiens_hsa04713 | 1.69158842 |
| 40 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.69013458 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.67914904 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.64375763 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.63431400 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.60762433 |
| 45 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.59747424 |
| 46 | Cocaine addiction_Homo sapiens_hsa05030 | 1.57476993 |
| 47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.55161259 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 1.54460832 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.52447583 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.52367199 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51059893 |
| 52 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.50537064 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.48177777 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.46632706 |
| 55 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.43744742 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.34185125 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.34066748 |
| 58 | Salivary secretion_Homo sapiens_hsa04970 | 1.33817792 |
| 59 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.31511467 |
| 60 | Huntingtons disease_Homo sapiens_hsa05016 | 1.31195686 |
| 61 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29030401 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.28846041 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24444456 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24066314 |
| 65 | Renin secretion_Homo sapiens_hsa04924 | 1.23369910 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.22531721 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.21369093 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 1.19294792 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.19026988 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18136432 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15730092 |
| 72 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.15393046 |
| 73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.15101731 |
| 74 | Bile secretion_Homo sapiens_hsa04976 | 1.13009837 |
| 75 | Long-term depression_Homo sapiens_hsa04730 | 1.12500134 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09640291 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.07831574 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.07008596 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.06693847 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.05292997 |
| 81 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.03609330 |
| 82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.02930712 |
| 83 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.98828241 |
| 84 | Axon guidance_Homo sapiens_hsa04360 | 0.97594137 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96440600 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95644063 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.93744090 |
| 88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92250404 |
| 89 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92138259 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.90929175 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90909535 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.90411731 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.90182010 |
| 94 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87557267 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86579262 |
| 96 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85812934 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84664794 |
| 98 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84658048 |
| 99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83099867 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.81519692 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81480262 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81299007 |
| 103 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77274189 |
| 104 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74323237 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.74108917 |
| 106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72121576 |
| 107 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69775617 |
| 108 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69169523 |
| 109 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.66676477 |
| 110 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.66162020 |
| 111 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.65043236 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62758506 |
| 113 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62420545 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61051920 |
| 115 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60261862 |
| 116 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59551526 |
| 117 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58682426 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57939731 |
| 119 | Gap junction_Homo sapiens_hsa04540 | 0.56917082 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55661375 |
| 121 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.55148105 |
| 122 | Proteasome_Homo sapiens_hsa03050 | 0.53244099 |
| 123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52927588 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52811790 |
| 125 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52490411 |
| 126 | ABC transporters_Homo sapiens_hsa02010 | 0.49565588 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48417640 |
| 128 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47425050 |
| 129 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45834236 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44882238 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44140216 |
| 132 | RNA polymerase_Homo sapiens_hsa03020 | 0.43732236 |
| 133 | Melanogenesis_Homo sapiens_hsa04916 | 0.43726787 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43385394 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.42047890 |
| 136 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41203933 |
| 137 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40330123 |
| 138 | Lysosome_Homo sapiens_hsa04142 | 0.39244050 |
| 139 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37427195 |
| 140 | Mismatch repair_Homo sapiens_hsa03430 | 0.37080049 |
| 141 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36656545 |
| 142 | Alcoholism_Homo sapiens_hsa05034 | 0.35237591 |
| 143 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34626168 |
| 144 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34607391 |
| 145 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33828869 |
| 146 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33632051 |
| 147 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32800783 |
| 148 | Homologous recombination_Homo sapiens_hsa03440 | 0.32005838 |
| 149 | Basal transcription factors_Homo sapiens_hsa03022 | 0.31290242 |
| 150 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30704341 |
| 151 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30672008 |
| 152 | Purine metabolism_Homo sapiens_hsa00230 | 0.30557068 |
| 153 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30401913 |
| 154 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.29554522 |
| 155 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.26118026 |
| 156 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.25022422 |
| 157 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.25006140 |
| 158 | Ribosome_Homo sapiens_hsa03010 | 0.24267071 |
| 159 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24163396 |
| 160 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23605959 |

